(Reuters) - A combination of experimental oral hepatitis C treatments being developed by Abbott Laboratories led to cure rates higher than 90 percent in previously untreated patients, according to data from a small mid-stage study.
ptz ip camera ge security systems thermal cameras
No comments:
Post a Comment